| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 04/03/2002 | EP1192950A1 Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as the active ingredient |
| 04/03/2002 | EP1192949A1 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient |
| 04/03/2002 | EP1192151A1 Anilinoquinazolines as protein tyrosine kinase inhibitors |
| 04/03/2002 | EP1192140A1 Substituted herbicidal phenyluracils |
| 04/03/2002 | EP1192127A1 Substituted benzamide inhibitors of rhinovirus 3c protease |
| 04/03/2002 | EP0948482B1 Method for producing trifluoroacetoacetic acid anilides |
| 04/03/2002 | EP0898567B1 N-aminoalkyl-1-biphenylenyl-2-carboxamides; dopamine receptor subtype specific ligands |
| 04/03/2002 | CN1343201A Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |
| 04/02/2002 | USRE37623 Enzyme inhibitors, their synthesis, and methods for use |
| 04/02/2002 | US6365740 Preparation of 2-methyl-4-amino-5-aminomethylpyrimidine |
| 04/02/2002 | US6365739 Reaction of aminopyramidine with phosgene to form isocyanato pyrimidine |
| 04/02/2002 | US6365738 Reaction with hydrazine, hydroxylamine or urea. thiourea, guanidine or aniline |
| 04/02/2002 | US6365195 Fungicidal active compound combinations |
| 04/02/2002 | US6365179 Conjugate having a cleavable linkage for use in a liposome |
| 04/02/2002 | US6365068 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
| 04/02/2002 | CA2253906C Process for preparation of pyrimidine derivatives |
| 04/02/2002 | CA2099868C Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
| 04/02/2002 | CA2097928C Uracil derivatives |
| 04/02/2002 | CA2051012C Carbocyclic adenosine analogs useful as immunosupressants |
| 03/28/2002 | WO2002024703A1 Bicyclic heteroaromatic compounds |
| 03/28/2002 | WO2002024667A1 4-amino-quinazolines |
| 03/28/2002 | WO2002024666A2 4-amino-quinazolines |
| 03/28/2002 | WO2002024665A1 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 03/28/2002 | WO2002024664A1 Method for separating and isolating in a highly purified manner low molecular, similar structured compounds, particularly tetrahydropyrimidine derivatives and fission products thereof |
| 03/28/2002 | WO2002024663A2 Pyrimidine compounds and their use |
| 03/28/2002 | WO2002024632A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 03/28/2002 | WO2002024250A1 Use of inos inhibitors for treating or preventing myopia |
| 03/28/2002 | WO2002024194A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 03/28/2002 | WO2001097751A3 New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
| 03/28/2002 | WO2001087281A3 Method for enhancing cognitive function |
| 03/28/2002 | US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes |
| 03/28/2002 | US20020037903 2-(2-pyrimidinyl),4-((hetero)arylalkylsulfonamido), 5-(2-methoxyphenoxy),6-methoxy-pyrimidine derivatives; treating endothelin-mediated disorders such as hypertension, congestive heart failure or chronic renal failure |
| 03/28/2002 | US20020037900 Hydroxamic acid derivatives |
| 03/28/2002 | US20020037896 Bicyclic compounds |
| 03/28/2002 | US20020037885 Therapeutic compounds |
| 03/28/2002 | CA2422820A1 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 03/28/2002 | CA2422560A1 4-amino-quinazolines |
| 03/28/2002 | CA2422488A1 4-amino-quinazolines |
| 03/27/2002 | EP1191611A2 Piezoelectric element and process for production thereof |
| 03/27/2002 | EP1191106A1 Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren |
| 03/27/2002 | EP1191023A1 Method of making dihydroperimidine squaraine compounds |
| 03/27/2002 | EP1189929A2 Factor viia inhibitors |
| 03/27/2002 | EP1189881A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 03/27/2002 | CN1342159A Process for preparation of 6-(perfluoroalkyl) uracil compounds |
| 03/27/2002 | CN1342140A 硫代酰胺衍生物 Thioamide derivatives |
| 03/27/2002 | CN1342137A N2 phenylamidine derivatives |
| 03/27/2002 | CN1081638C Thienopyrimidines |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/27/2002 | CN1081624C Benzamide analogs, useful as PARP (ADP-ribosyltransferase, ADRPT) DNA repair enzyme inhibitors |
| 03/27/2002 | CA2321348A1 Aromatic derivatives with hiv integrase inhibitory properties |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362337 Substituted phenyluracils |
| 03/26/2002 | US6362336 Administering a quinazoline derivative to a warm-blooded animal for producing an antiangiogenic and/or vascular permeability reducing effect |
| 03/26/2002 | US6362232 Skin disorers; insecticides |
| 03/26/2002 | US6362193 Antiinflammatory agents |
| 03/26/2002 | US6362177 Cyclic amine derivatives and their use as drugs |
| 03/26/2002 | CA2137953C Benzenesulfonamide derivative and process for preparing thereof |
| 03/26/2002 | CA2095848C Process for the preparation of pyrimidine compounds |
| 03/21/2002 | WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022605A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022604A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022603A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022602A2 Triazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022601A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022588A1 Novel pyrimidine derivative and novel pyridine derivative |
| 03/21/2002 | WO2002022553A2 Non-natural basic amino acids, their preparation and use |
| 03/21/2002 | WO2001081346A3 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 03/21/2002 | WO2001066099A3 Use of quinazoline derivatives as angiogenesis inhibitors |
| 03/21/2002 | WO2001034136A3 Use of adatanserin for the treatment of neurodegenerative conditions |
| 03/21/2002 | US20020035254 Processes and intermediates for preparing retroviral protease inhibitors |
| 03/21/2002 | US20020035253 Contacting qinazolinone with cyclopropylacetylene |
| 03/21/2002 | US20020035109 Benzamidine derivatives and their use as anti-coagulants |
| 03/21/2002 | US20020035092 Propanoic acid derivatives |
| 03/21/2002 | US20020035064 Method for treating atherosclerosis employing an aP2 inhibitor and combination |
| 03/21/2002 | CA2459599A1 Non-natural basic amino acids, their preparation and use |
| 03/21/2002 | CA2357469A1 Process for producing non-proteinogenic l-amino acids by fermentation |
| 03/20/2002 | EP1188750A1 Process for the preparation of 2,5-diamino-4,6-dihalogenopyrimidinen |
| 03/20/2002 | EP1188745A1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same |
| 03/20/2002 | EP1187838A1 Thiazolopyrimidines useful as tnf-alpha inhibitors |
| 03/20/2002 | EP1187817A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 03/20/2002 | EP1187816A1 5-cyano-2-aminopyrimidine derivatives |
| 03/20/2002 | EP1187815A1 4-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP1187814A2 5-phenyl-pyrimidine derivatives |
| 03/20/2002 | EP1187592A2 Alpha v integrin receptor antagonists |
| 03/20/2002 | EP1156040A4 2,4-dioxo-5-arylidenimino-1,3-pyrimidines |
| 03/20/2002 | EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/20/2002 | EP0929508B1 Liquid crystalline (e,e)-butadiene compounds and mixtures and devices containing such compounds |
| 03/20/2002 | CN1341104A 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases |
| 03/20/2002 | CN1081185C N-arylthiohydrazone derivatives as insecticidal and acaricidal agents |
| 03/19/2002 | US6359134 Sulfonamide derivatives, their production and use |
| 03/19/2002 | US6359133 Halogen pyrimidinyl aryl (thio) ethers as pesticides |
| 03/19/2002 | US6358962 6,7-Dimethoxyquinazolines and therapeutic use thereof |
| 03/19/2002 | US6358961 Farnesyltransferase inhibiting quinazolinones |
| 03/19/2002 | US6358959 Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists |
| 03/19/2002 | US6358948 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 03/19/2002 | US6358922 Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides |
| 03/19/2002 | US6358515 Hydroquinone derivatives |
| 03/19/2002 | US6358504 Compounds and compositions for delivering active agents |